{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:34:39Z","timestamp":1790066079239,"version":"4.0.1"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.18223","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:31:29Z","timestamp":1627054289000},"page":"e2118223","source":"Crossref","is-referenced-by-count":76,"title":["Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada"],"prefix":"10.1001","volume":"4","author":[{"given":"Paul J.","family":"Joudrey","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe M.","family":"Adams","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paxton","family":"Bach","sequence":"additional","affiliation":[{"name":"British Columbia Center on Substance Use, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Van Buren","sequence":"additional","affiliation":[{"name":"Yale School of Nursing, Orange, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Chaiton","sequence":"additional","affiliation":[{"name":"British Columbia Center on Substance Use, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Ehrenfeld","sequence":"additional","affiliation":[{"name":"Yale School of Nursing, Orange, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Elizabeth","family":"Guerra","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynna","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Vassar College, Poughkeepsie, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon D.","family":"Kimmel","sequence":"additional","affiliation":[{"name":"Sections of General Internal Medicine and Infectious Diseases, Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Medley","sequence":"additional","affiliation":[{"name":"Yale School of Nursing, Orange, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Mekideche","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Paquet","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhee","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"VA Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. O. Olivier","family":"You Kheang","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"issue":"11","key":"zoi210537r2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017-2018.","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"zoi210537r3","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2020.17477","article-title":"Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic.","volume":"324","author":"Ochalek","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"zoi210537r4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi210537r5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1001\/jamapsychiatry.2020.1511","article-title":"Methadone for opioid use disorder-decades of effectiveness but still miles away in the us.","volume":"77","author":"Joudrey","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"zoi210537r6","first-page":"1","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.","author":"Wang","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"1","key":"zoi210537r7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7326\/M20-1210","article-title":"When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis.","volume":"173","author":"Becker","year":"2020","journal-title":"Ann Intern Med"},{"key":"zoi210537r8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108011","article-title":"Appointment wait-times and arrival for patients at a low-barrier access addiction clinic.","volume":"114","author":"Roy","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi210537r9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archpsyc.63.1.102","article-title":"A randomized controlled trial of interim methadone maintenance.","volume":"63","author":"Schwartz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"zoi210537r10","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: what the United States can learn from the global effort to treat opioid addiction.","volume":"34","author":"Calcaterra","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi210537r13","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1097\/ADM.0000000000000679","article-title":"Opioid policy changes during the COVID-19 pandemic\u2014and beyond.","volume":"14","author":"Davis","year":"2020","journal-title":"J Addict Med"},{"key":"zoi210537r15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2019.01.020","article-title":"Comparing Canadian and United States opioid agonist therapy policies.","volume":"74","author":"Priest","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"9","key":"zoi210537r18","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s10461-020-02887-1","article-title":"Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at high-risk for HIV in an opioid treatment program.","volume":"24","author":"Peavy","year":"2020","journal-title":"AIDS Behav"},{"issue":"3","key":"zoi210537r19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08897077.2018.1488336","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.","volume":"40","author":"Patrick","year":"2019","journal-title":"Subst Abus"},{"issue":"8","key":"zoi210537r20","doi-asserted-by":"publisher","first-page":"e2013456","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of pregnancy and insurance status with treatment access for opioid use disorder.","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi210537r26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M18-3457","article-title":"Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study.","volume":"171","author":"Beetham","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi210537r28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08897077.2013.819828","article-title":"A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.","volume":"35","author":"Fingerhood","year":"2014","journal-title":"Subst Abus"},{"issue":"8","key":"zoi210537r30","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/add.v113.8","article-title":"An investigation of an open-access model for scaling up methadone maintenance treatment.","volume":"113","author":"Madden","year":"2018","journal-title":"Addiction"},{"key":"zoi210537r33","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000813","article-title":"Treatment Disruption and Childcare Responsibility as Risk Factors for Drug and Alcohol Use in Persons in Treatment for Substance Use Disorders During the COVID-19 Crisis.","author":"Huhn","year":"2021","journal-title":"J Addict Med"},{"issue":"13","key":"zoi210537r34","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US states.","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi210537r35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1475-6773.12686","article-title":"Geographic disparities in availability of opioid use disorder treatment for Medicaid enrollees.","volume":"53","author":"Abraham","year":"2018","journal-title":"Health Serv Res"},{"issue":"1","key":"zoi210537r36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities.","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"zoi210537r37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ADM.0000000000000156","article-title":"Evaluating the effectiveness of first-time methadone maintenance therapy across northern, rural, and urban regions of Ontario, Canada.","volume":"9","author":"Eibl","year":"2015","journal-title":"J Addict Med"},{"key":"zoi210537r38","author":"Joseph","journal-title":"J Subst Abuse Treat"},{"key":"zoi210537r39","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108534","article-title":"Expanding access to methadone treatment in Ohio through federally qualified health centers and a chain pharmacy: a geospatial modeling analysis.","volume":"220","author":"Iloglu","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi210537r40","article-title":"COVID-19 and Public Transportation: Current Assessment, Prospects, and Research Needs.","volume":"22","author":"Tirachini","year":"2020","journal-title":"J Public Trans"},{"issue":"10","key":"zoi210537r41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/adaw.32650","article-title":"DEA proposal for mobile methadone finally released.","volume":"32","author":"Knopf","year":"2020","journal-title":"Alcoholism & Drug Abuse Weekly"},{"issue":"3","key":"zoi210537r42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ps.201900373","article-title":"Private coverage of methadone in outpatient treatment programs.","volume":"71","author":"Polsky","year":"2020","journal-title":"Psychiatr Serv"},{"issue":"7","key":"zoi210537r43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0706743717711167","article-title":"The state of opioid agonist therapy in Canada 20 years after federal oversight.","volume":"62","author":"Eibl","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"2","key":"zoi210537r44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10826084.2017.1325376","article-title":"Primary care physicians\u2019 views about prescribing methadone to treat opioid use disorder.","volume":"53","author":"Livingston","year":"2018","journal-title":"Subst Use Misuse"},{"issue":"2","key":"zoi210537r45","first-page":"e95","article-title":"Patterns of methadone maintenance treatment provision in Ontario: policy success or pendulum excess?","volume":"64","author":"Kurdyak","year":"2018","journal-title":"Can Fam Physician"},{"key":"zoi210537r17","doi-asserted-by":"crossref","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"Leshner","DOI":"10.17226\/25310"},{"key":"zoi210537r1","unstructured":"Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid-related harms in Canada. Accessed August 27, 2020. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids\/"},{"key":"zoi210537r11","unstructured":"Priest? KC. The COVID-19 pandemic: practice and policy considerations for patients with opioid use disorder. HealthAffairs. Published 2020. Accessed October 27, 2020. https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20200331.557887\/full\/"},{"key":"zoi210537r12","unstructured":"SAMHSA. Opioid Treatment Program (OTP) guidance. Published 2020. Accessed June 18, 2021. https:\/\/www.samhsa.gov\/sites\/default\/files\/otp-guidance-20200316.pdf"},{"key":"zoi210537r14","unstructured":"Lam? V, Sankey? C, Wyman? J, Zhang? M. COVID-19 opioid agonist treatment guidance. Published online 2020. Accessed June 18, 2021. https:\/\/www.camh.ca\/-\/media\/files\/covid-19-modifications-to-opioid-agonist-treatment-delivery-pdf.pdf?la=en&hash=261C3637119447097629A014996C3C422AD5DB05"},{"key":"zoi210537r16","unstructured":"Bruneau? J, Rehm? J, Wild? TC, . Telemedicine support for addiction services: national rapid guidance document. Published 2020. Accessed June 18, 2021. https:\/\/crism.ca\/wp-content\/uploads\/2020\/05\/CRISM-National-Rapid-Guidance-Telemedicine-V1.pdf"},{"key":"zoi210537r21","unstructured":"SAMHSA. Behavioral health treatment services locator. Accessed August 27, 2020. https:\/\/findtreatment.samhsa.gov\/"},{"key":"zoi210537r22","unstructured":"Alberta Health Services. Addiction and mental health. Accessed August 27, 2020. https:\/\/www.albertahealthservices.ca\/amh\/amh.aspx"},{"key":"zoi210537r23","unstructured":"ConnexOntario. Addiction, mental health, and problem gambling treatment services. Accessed August 27, 2020. https:\/\/www.connexontario.ca\/"},{"key":"zoi210537r24","unstructured":"British Columbia Centre on Substance Use. OAT clinics accepting new patients. Accessed August 27, 2020. https:\/\/www.bccsu.ca\/oat-clinics-accepting-new-patients\/"},{"key":"zoi210537r25","unstructured":"Kaiser Family Foundation. Status of state Medicaid expansion decisions: interactive map. Published November 2, 2020. Accessed December 2, 2020. https:\/\/www.kff.org\/medicaid\/issue-brief\/status-of-state-medicaid-expansion-decisions-interactive-map\/"},{"key":"zoi210537r27","unstructured":"Orgera? K, Tolbert? J. Key facts about uninsured adults with opioid use disorder. Kaiser Family Foundation. Published July 15, 2019. Accessed October 27, 2020. https:\/\/www.kff.org\/uninsured\/issue-brief\/key-facts-about-uninsured-adults-with-opioid-use-disorder\/"},{"key":"zoi210537r29","unstructured":"Musumeci? MB, Tobert? J. Federal legislation to address the opioid crisis: Medicaid provisions in the SUPPORT Act. Kaiser Family Foundation. Published October 5, 2018. Accessed January 24, 2021. https:\/\/www.kff.org\/medicaid\/issue-brief\/federal-legislation-to-address-the-opioid-crisis-medicaid-provisions-in-the-support-act\/"},{"key":"zoi210537r31","unstructured":"HRSA. Federal Office of Rural Health Policy (FORHP) Data Files. Official website of the U.S. Health Resources & Services Administration. Published April 28, 2017. Accessed August 27, 2020. https:\/\/www.hrsa.gov\/rural-health\/about-us\/definition\/datafiles.html"},{"key":"zoi210537r32","unstructured":"Statistics Canada. Postal Code Conversion File. Published December 13, 2017. Accessed August 27, 2020. https:\/\/www150.statcan.gc.ca\/n1\/en\/catalogue\/92-154-X"},{"key":"zoi210537r46","unstructured":"Public Health Agency of Canada. Coronavirus disease (COVID-19): outbreak update. Published August 4, 2020. Accessed August 27, 2020. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/2019-novel-coronavirus-infection.html"},{"key":"zoi210537r47","unstructured":"Johns Hopkins Coronavirus Resource Center. Impact of opening and closing decisions by state. Accessed October 2, 2020. https:\/\/coronavirus.jhu.edu\/data\/state-timeline"},{"key":"zoi210537r48","unstructured":"USAFacts. US coronavirus cases and deaths. Published August 27, 2020. Accessed August 27, 2020. https:\/\/usafacts.org\/visualizations\/coronavirus-covid-19-spread-map"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2782211\/joudrey_2021_oi_210537_1626356057.3978.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T15:31:53Z","timestamp":1627054313000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2782211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18223","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}